May 08, 2020
InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020
May 07, 2020
InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference
Mar 20, 2020
InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak
Mar 12, 2020
American Shaman Debuts First-Of-Its-Kind Sleep Product
Mar 10, 2020
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Feb 18, 2020
Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form
Jan 21, 2020
InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview
Jan 20, 2020
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
Aug 06, 2019
Continued Research Reveals Notable Details on Cannabis' Efficacy
Aug 05, 2019
CBD, the Latest Wellness Craze, Won't Cause Users to Fail a Drug Test--but Its Lesser-Known Cousin CBN Will
Apr 15, 2019
Librede Inc. Receives Patent for Tetrahydrocannabinolic acid (THCA) Production in Yeast
Mar 04, 2019
Citrus CBD is the First All-Natural, Non-Hemp CBD Available in a Transdermal Patch
Dec 12, 2018
Exploring the Lesser Cannabinoids - The Happy Accident of CBN
Jun 22, 2018
International Multi-Centre Collaboration Reveals that Cannabigerol Acts Directly on Cannabinoid Receptors CB1 and CB2
Jun 06, 2017
Legal Cannabis and CBD Markets are Projected to Grow